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Maianga-Luanda, Angola
3CISAS-Center for Research and Development in Agrifood Systems and Sustainability, Instituto Politécnico de Viana Do Castelo,
Viana Do Castelo, Portugal
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Spotted fever group Rickettsia (SFGR) is one among the aetiologies that cause fever of unknown origin in Angola. Despite their
occurrence, there is little information about its magnitude in this country either because it is misdiagnosed or due to the lack of
diagnostic resources. For this purpose, eighty-seven selected malaria- and yellow fever-negative serum specimens collected
between February 2016 and March 2017 as part of the National Laboratory of Febrile Syndromes, from patients with fever
(≥37.5°C) for at least 4 days and of unknown origin, were screened for Rickettsia antibodies through an immunofluorescence assay
(IFA). Serological results were interpreted according to the 2017 guidelines for the detection of Rickettsia spp. -ree seroreactive
patients had detectable IgM antibodies to Rickettsiawith an endpoint titre of 32 and IgG antibodies with endpoint titres of 128 and
256. -ese findings supported a diagnosis of Rickettsia exposure amongst these patients and highlight that rickettsioses may be
among the cause of unknown febrile syndromes in Angola. -erefore, physicians must be aware of this reality and must include
this vector-borne disease as part of aetiologies that should be considered and systematically tested in order to delineate appropriate
strategies of diagnostic and control of Rickettsia in Angola.
1. Introduction
Rickettsioses are vector-borne diseases of medical impor-
tance, particularly in African countries where an increasing
number of cases have been reported amongst residents and
tourists [1]. Despite its public health importance, the epi-
demiological characteristics linked to rickettsial diseases are
poorly defined in the African continent [2]. Rickettsia
species are strictly intracellular, Gram-negative bacteria
from the order Rickettsiales comprising 30 recognized
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species and numerous uncharacterized strains [3]. Ticks are
vectors and reservoirs for several rickettsial agents, but some
Rickettsia spp. are transmitted by fleas, lice, and mites [4].
-ese bacteria present several antigenically distinct groups,
with those belonging to the spotted fever group (SFG)
remaining an important cause of human and animal dis-
eases, characterized by vascular invasion and tissue necrosis
[5]. -e classical triad of clinical manifestations of SFG
Rickettsia infection includes fever, eschar, and rash [6];
however, these vary depending on the rickettsial species
involved.
In Angola, a high percentage of the population lives in
suburban neighbourhoods, characterized by adobe and
cement constructed houses with limited access to public
basic resources such as potable water, energy supply, health,
and education. -ese highly unhealthy living conditions
associated with domestic animals in close proximity increase
the exposure to ectoparasites and to the pathogens that they
might harbour.
Many studies report rickettsioses acquired by travellers,
but the majority refers to sub-Saharan Africa tourists who
develop African tick-bite fever (ATBF) [1]. In African
countries, fevers of unknown origin can have different ae-
tiologies including rickettsial infection but, due to the
overlapping symptomatology with other endemic diseases
(e.g., malaria, dengue, HIV, and brucellosis) that also cause
fever, as well as the lack of available diagnostic tests and
laboratory resources [7], rickettsioses are often under-
diagnosed [2].
-e aim of this study was to perform the laboratory
diagnosis of Rickettsia spp. exposure among febrile patients
from Angola with malaria and yellow fever already clinically
and laboratory discarded.
2. Methods
2.1. Sample Collection. Between February 2016 and March
2017, a total of 87 serum specimens were obtained from
public hospitals, as part of the Febrile Syndrome Sur-
veillance Programme of Angola. -ese serum specimens
were collected from patients from different cities (Ben-
guela, Cabinda, Huambo, Luanda, and Malanje) and
provinces (Huı́la, Kwanza Sul, Kwanza Norte, Lunda
Norte, and Zaire) of Angola and were selected for this
study if belonging to individuals presenting fever for at
least four days (≥37.5°C) and with at least one of the
following inclusion criteria: malaise, myalgia, arthralgia,
nausea, vomiting, and rash. -ese selected serum speci-
mens were also malaria and yellow fever negative, pre-
viously tested through peripheral blood smear, malaria
antigen detection test (SD BIOLINE), and RT-PCR,
respectively.
A questionnaire including patient demographic (age
and gender) and epidemiological data (province and
municipality of origin, type of residence, household
characteristics, season of specimen collection, access to
potable water, contact with animals, and clinical mani-
festations) was filled for each patient by the health care
professionals.
2.2. Serological Testing. Sera were tested by an in-house
immunofluorescence assay (IFA) using R. africae strain as
antigen, prepared at the Portuguese National Institute of
Health Dr. Ricardo Jorge, as previously reported [8]. Along
with fever, Rickettsia exposure was defined when the sera
presented both IgG titre ≥64 and IgM titre ≥32, according to
the previously published guidelines for the detection of
Rickettsia spp. [9].
3. Results
A total of 87 patients from 10 different cities and provinces
were analysed in this study (Figure 1). Out of the 87 patients,
27 (31%) were females and 60 (69%) were males. Patients’
age ranged between 1 and 86 years, with 45% included in the
13–26 years interval. Eighty-three percent (72/87) of the
participants lived in urban areas, while the remaining 17%
(15/87) lived in rural areas. All the patients had contact with
domestic animals such as dogs, cats, and chickens.
Of all sera from febrile patients of Angola analysed
(n� 87), three (3.5%; 95% CI: 1.2–9.7) clearly met the lab-
oratory definition of Rickettsia exposure. One presented IgG
antibody titre of 128 and IgM antibody titre of 32 and the
other two seroreactive sera presented IgG antibody titre of
256 and IgM antibody titre of 32. Of the 3 seropositive
individuals, two were females and one was a male, with ages
ranging from 15 to 34 years, living in Luanda and Benguela
cities.
4. Discussion
Rickettsia spp. is distributed worldwide, but the knowledge
about their epidemiology and their health impact in Africa is
scarce, with most serological studies focusing on IgG
seroprevalence, namely, in South Africa [10, 11], Djibouti
[12], Kenya [13, 14], Tunisia [15], Cameroon [16], Zimbabwe
[17], Ivory Coast [18], Egypt [19], and Angola [20].
Rickettsioses are rarely considered when evaluating
patients with undifferentiated febrile illnesses, and due to the
overlapping symptomatology with other endemic diseases
such as malaria, dengue, and yellow fever, diagnosis is
difficult without confirmatory laboratory tests.
Our study aimed at ascertaining the association of
Rickettsia exposure with fever of unknown origin by
screening febrile patients from Angola that had been pre-
viously found to be negative for malaria and yellow fever.
-e IFA is currently the gold standard test for serological
diagnosis of Rickettsia [9, 21]. However, the cross-reactivity
of this methodology does not allow the identification of the
specific infecting Rickettsia species [22]. Several Rickettsia
antigens should have been tested; however, due to serum
sample volume constraints, as well as the availability of IFA
slides coated only with R. africae antigen, the patient samples
were only tested for this SFG species.
-is study has detected three Rickettsia exposed patients
among previously undiagnosed febrile patients (3.5%; 95%
CI: 1.2–9.7).
Interestingly, these results are similar to a study reported
by Botros and collaborators [19], in which only 1% of the
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Egyptian garbage collectors tested presented seroreactivity
against R. conorii. Nevertheless, the herein study presents
lower seroreactive serum samples when compared with
other reports, demonstrating 17.68% of human Rickettsia
exposure in Reunion Island, Southern Africa [23]; 21% in
febrile patients from Mpumalanga, South Africa [10]; 24.1%
in a pastoral HIV-endemic community of South Africa [11];
16% in workers from a Djiboutian abattoir in East Africa
[12]; 10% of febrile patients from Kenya; 22.4% of febrile
children from western Kenya [14]; 66% of patients with fever
of undetermined origin from Tunisia [15]; 32% of febrile
patients from Cameroon [16]; and finally, 5.3% and 6.2% of a
rural population of Sierra Leone and Ivory Coast, respec-
tively [18].
Despite the important message that our results may
arouse regarding a possible Rickettsia exposure, for several
reasons, they should be carefully analysed and interpreted.
According to Brouqui and collaborators [24], Rickettsia IgM
and IgG antibodies are usually detected seven to 15 days after
disease onset. -e patients herein tested presented fever for
at least 4 days. However, we cannot know exactly how long
this clinical manifestation lasts, which makes it impossible to
critically contextualize with the respective serological data.
On the contrary, it is important to be aware that IgM cross
reactions with other pathogenic agents or false-positive IgM
antibodies observed, for instance, when rheumatoid factor is
present, may occur, as described in the guidelines for the
detection of Rickettsia spp. [9]. Even though, our detected
cases of IgM positive specimens were accompanied with
positive titres of IgG (128 and 256) which, taken together,
may reinforce the premise that rickettsiae are circulating in
Angola. Nevertheless, and ideally, in order to confirm a
current rickettsiae infection, these patients should be
retested and checked for seroconversion or increased an-
tibody titres in matched samples at 3-week intervals.
-e transmission and dissemination of rickettsiae
through vectors are a phenomenon of growing concern with
the expanding human populations and increasing contact
between humans and animals (domestic and wildlife) [25].
-e rickettsiae-exposed patients who participated in our
study lived in urban zones of Benguela and Luanda cities.
One of them is a student, and the other two street vendors. A
previous study done in pet dogs from Luanda [26] described
a low Rickettsia seroprevalence in these animal species.
Probably, ticks and fleas competent for Rickettsia appear
with a low rate of parasitism in Angola.
Although in a low prevalence, this finding is relevant to
the clinical management of patients with fever of unknown
10°00′00.000″E
5°
00
′
00
.0
00
″
S
10
°0
0′
00
.0
00
″
S
15
°0
0′
00
.0
00
″
S
–1
50
00
00
.0
00
5°
00
′
00
.0
00
″
S
10
°0
0′
00
.0
00
″
S
15
°0
0′
00
.0
00
″
S
–1
50
00
00
.0
00
15°00′00.000″E 20°00′00.000″E 25°00′00.000″E 3000000.0001500000.000
10°00′00.000″E 15°00′00.000″E 20°00′00.000″E 25°00′00.000″E 3000000.0001500000.000
100 100 200 300 400 km0
Samples
>20
[5–20]
[0–5]
Municipalities
Figure 1: Study area with Angola sampling location cities (Benguela, Cabinda, Huambo, Luanda, and Malanje) and provinces (Huı́la,
Kwanza Sul, Kwanza Norte, Lunda Norte, and Zaire).
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origin and support the inclusion of this VBD in clinical
diagnostic algorithms.
To conclude, our findings suggest that rickettsioses are
present in Angola and, therefore, should be taken into ac-
count in cases of febrile illness. -e serological evidence of
exposure with these bacteria raises attention for the need of
appropriated public health interventions and diagnostic
improvement. Forthcoming studies should include a higher
specimen number, with the possibility of detecting the
pathogen in acute infection phases, both acute and conva-
lescent samples screening, antibodies testing against several
antigens, and, if possible, application of molecular tech-
niques in skin biopsy or swab samples from suspected cases
with eschar. -is will allow the identification of risk factors
and the establishment of prevention and control disease
strategies for Rickettsia spp. infection.
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and J. A. Oteo, “Rickettsioses in Europe,” Microbes and In-
fection, vol. 17, no. 11-12, pp. 834–838, 2015.
[5] S. N. Shpynov, P.-E. Fournier, N. N. Pozdnichenko,
A. S. Gumenuk, and A. A. Skiba, “New approaches in the
systematics of rickettsiae,” New Microbes and New Infections,
vol. 23, pp. 93–102, 2018.
[6] A. Portillo and J. A. Oteo, “Rickettsiosis as threat for the
traveller,” in Current Topics in Tropical Medicine, IntechOpen,
London, UK, 2012.
[7] M. J. Maze, Q. Bassat, N. A. Feasey, I. Mandomando,
P. Musicha, and J. A. Crump, “-e epidemiology of febrile
illness in sub-Saharan Africa: implications for diagnosis and
management,” Clinical Microbiology and Infection, vol. 24,
no. 8, pp. 808–814, 2018.
[8] F. Bacellar, R. Sousa, A. Santos, M. Santos-Silva, and P. Parola,
“Boutonneuse fever in Portugal: 1995-2000. data of a state
laboratory,” European Journal of Epidemiology, vol. 18, no. 3,
pp. 275–277, 2002.
[9] A. Portillo, R. de Sousa, S. Santibáñez et al., “Guidelines for the
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